These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 16483879)

  • 1. Metabolism of gamma-hydroxybutyrate to d-2-hydroxyglutarate in mammals: further evidence for d-2-hydroxyglutarate transhydrogenase.
    Struys EA; Verhoeven NM; Jansen EE; Ten Brink HJ; Gupta M; Burlingame TG; Quang LS; Maher T; Rinaldo P; Snead OC; Goodwin AK; Weerts EM; Brown PR; Murphy TC; Picklo MJ; Jakobs C; Gibson KM
    Metabolism; 2006 Mar; 55(3):353-8. PubMed ID: 16483879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catabolism of GABA, succinic semialdehyde or gamma-hydroxybutyrate through the GABA shunt impair mitochondrial substrate-level phosphorylation.
    Ravasz D; Kacso G; Fodor V; Horvath K; Adam-Vizi V; Chinopoulos C
    Neurochem Int; 2017 Oct; 109():41-53. PubMed ID: 28300620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered cerebral glucose and acetate metabolism in succinic semialdehyde dehydrogenase-deficient mice: evidence for glial dysfunction and reduced glutamate/glutamine cycling.
    Chowdhury GM; Gupta M; Gibson KM; Patel AB; Behar KL
    J Neurochem; 2007 Dec; 103(5):2077-91. PubMed ID: 17854388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D-2-hydroxyglutaric aciduria in three patients with proven SSADH deficiency: genetic coincidence or a related biochemical epiphenomenon?
    Struys EA; Verhoeven NM; Salomons GS; Berthelot J; Vianay-Saban C; Chabrier S; Thomas JA; Tsai AC; Gibson KM; Jakobs C
    Mol Genet Metab; 2006 May; 88(1):53-7. PubMed ID: 16442322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic intervention in mice deficient for succinate semialdehyde dehydrogenase (gamma-hydroxybutyric aciduria).
    Gupta M; Greven R; Jansen EE; Jakobs C; Hogema BM; Froestl W; Snead OC; Bartels H; Grompe M; Gibson KM
    J Pharmacol Exp Ther; 2002 Jul; 302(1):180-7. PubMed ID: 12065715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzymatic and metabolic evidence for a region specific mitochondrial dysfunction in brains of murine succinic semialdehyde dehydrogenase deficiency (Aldh5a1-/- mice).
    Sauer SW; Kölker S; Hoffmann GF; Ten Brink HJ; Jakobs C; Gibson KM; Okun JG
    Neurochem Int; 2007 Mar; 50(4):653-9. PubMed ID: 17303287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic characterization of human hydroxyacid-oxoacid transhydrogenase: relevance to D-2-hydroxyglutaric and gamma-hydroxybutyric acidurias.
    Struys EA; Verhoeven NM; Ten Brink HJ; Wickenhagen WV; Gibson KM; Jakobs C
    J Inherit Metab Dis; 2005; 28(6):921-30. PubMed ID: 16435184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxicologic/transport properties of NCS-382, a γ-hydroxybutyrate (GHB) receptor ligand, in neuronal and epithelial cells: Therapeutic implications for SSADH deficiency, a GABA metabolic disorder.
    Vogel KR; Ainslie GR; McConnell A; Roullet JB; Gibson KM
    Toxicol In Vitro; 2018 Feb; 46():203-212. PubMed ID: 29031482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Focal neurometabolic alterations in mice deficient for succinate semialdehyde dehydrogenase.
    Gibson KM; Schor DS; Gupta M; Guerand WS; Senephansiri H; Burlingame TG; Bartels H; Hogema BM; Bottiglieri T; Froestl W; Snead OC; Grompe M; Jakobs C
    J Neurochem; 2002 Apr; 81(1):71-9. PubMed ID: 12067239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for a role of high Km aldehyde reductase in the degradation of endogenous gamma-hydroxybutyrate from rat brain.
    Vayer P; Schmitt M; Bourguignon JJ; Mandel P; Maitre M
    FEBS Lett; 1985 Oct; 190(1):55-60. PubMed ID: 3899725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative genomics of aldehyde dehydrogenase 5a1 (succinate semialdehyde dehydrogenase) and accumulation of gamma-hydroxybutyrate associated with its deficiency.
    Malaspina P; Picklo MJ; Jakobs C; Snead OC; Gibson KM
    Hum Genomics; 2009 Jan; 3(2):106-20. PubMed ID: 19164088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GHB receptor targets in the CNS: focus on high-affinity binding sites.
    Bay T; Eghorn LF; Klein AB; Wellendorph P
    Biochem Pharmacol; 2014 Jan; 87(2):220-8. PubMed ID: 24269284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotransmitter alterations in embryonic succinate semialdehyde dehydrogenase (SSADH) deficiency suggest a heightened excitatory state during development.
    Jansen EE; Struys E; Jakobs C; Hager E; Snead OC; Gibson KM
    BMC Dev Biol; 2008 Nov; 8():112. PubMed ID: 19040727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Succinic semialdehyde dehydrogenase deficiency: GABAB receptor-mediated function.
    Buzzi A; Wu Y; Frantseva MV; Perez Velazquez JL; Cortez MA; Liu CC; Shen LQ; Gibson KM; Snead OC
    Brain Res; 2006 May; 1090(1):15-22. PubMed ID: 16647690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutants of GABA transaminase (POP2) suppress the severe phenotype of succinic semialdehyde dehydrogenase (ssadh) mutants in Arabidopsis.
    Ludewig F; Hüser A; Fromm H; Beauclair L; Bouché N
    PLoS One; 2008; 3(10):e3383. PubMed ID: 18846220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An overview of gamma-hydroxybutyrate catabolism: the role of the cytosolic NADP(+)-dependent oxidoreductase EC 1.1.1.19 and of a mitochondrial hydroxyacid-oxoacid transhydrogenase in the initial, rate-limiting step in this pathway.
    Kaufman EE; Nelson T
    Neurochem Res; 1991 Sep; 16(9):965-74. PubMed ID: 1784339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GABA shunt deficiencies and accumulation of reactive oxygen intermediates: insight from Arabidopsis mutants.
    Fait A; Yellin A; Fromm H
    FEBS Lett; 2005 Jan; 579(2):415-20. PubMed ID: 15642352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of γ-hydroxybutyrate in perfused rat livers.
    Zhang GF; Sadhukhan S; Ibarra RA; Lauden SM; Chuang CY; Sushailo S; Chatterjee P; Anderson VE; Tochtrop GP; Brunengraber H
    Biochem J; 2012 Jun; 444(2):333-41. PubMed ID: 22428548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GABA, gamma-hydroxybutyric acid, and neurological disease.
    Wong CG; Bottiglieri T; Snead OC
    Ann Neurol; 2003; 54 Suppl 6():S3-12. PubMed ID: 12891648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4-Hydroxybutyric acid and the clinical phenotype of succinic semialdehyde dehydrogenase deficiency, an inborn error of GABA metabolism.
    Gibson KM; Hoffmann GF; Hodson AK; Bottiglieri T; Jakobs C
    Neuropediatrics; 1998 Feb; 29(1):14-22. PubMed ID: 9553943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.